Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Eli Lilly and Company
With
ICOS Corporation
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Must have participated and discontinued in the previous PAH placebo controlled study due to clinical worsening on placebo or tadalafil 2.5 mg, 10mg, or 20 mg
Must have completed Week 16 of the previous PAH study and had either no clinical worsening or became clinically worse at the Week 16 visit on placebo or tadalafil 2.5 mg, 10mg, or 20 mg
Females who have a negative urine pregnancy test and are willing to use 2 types of birth control
Be 12 years or older (country specific regulations apply) with parental approval
You may not be if
Participated in the placebo controlled study and had clinical worsening on 40 mg tadalafil
Have left-sided heart disease
Have a musculoskeletal disorder that limits being able to get around